10 mg retatrutide (10mg) 10mg Disposable Injection Pen for

Clinical Evidence 2026 Update: Phase 3 TRIUMPH Data In December 2025, Eli Lilly reported the first successful Phase 3 readout for retatrutide (LY3437943) from the TRIUMPH-4 trial

Diet and physical activity Retatrutide is not a magic override for unlimited caloric intake

doi: 10.1210/jc.2012-3855 205 KimMPlattMJShibasakiTQuagginSEBackxPHSeinoSet al

Inulin could reverse these alterations and reduce the number of macrophages ( Effects of inulin and its metabolites on IECs Reduced intestinal mucosal tolerance promotes immune-mediated inflammatory diseases

The vial still contains 10 mg regardless of dilution

Most states allow asynchronous telehealth consultations for GLP-1 prescribing